Epidemiological observations have provided evidence that higher circulating insulin levels are associated with an adverse outcome in early BC patients.148,149 From this perspective, the insulin pathway may represent a therapeutic target, especially in patients with high plasma insulin levels. The gene discussed is INS; the disease is breast cancer.